A book by Dragon’s Den panellists is full of insights for fledgling entrepreneurs, says Ian Mann.
All claims of fact made in the media should be verifiable, says Mandi Smallhorne.
It has been a grave mistake to defy both Russia and France, says Leopold Scholtz.
Pfizer and Allergan has agreed to combine in a $160bn deal, creating a drugmaking behemoth called Pfizer with products from Viagra to Botox and a low-cost tax base.
The Bonitas Medical Fund has a new plan to tackle the prevalence of healthcare fraud, including increasing collusion between medical aid members and healthcare providers.
Netcare Group's results reflect a solid performance from operations in South Africa, despite a more difficult economic environment, says CEO Richard Friedland.
Health and care brands group Ascendis Health has announced that it has acquired another pharmaceutical business for R345m.
Life Healthcare has announced a full-year group revenue rise of 12.3% to R14 647m, with expansion in Poland and India a focus for the group.
More than 100 women who became pregnant after taking mislabelled birth control pills have filed suit in the US, seeking millions of dollars in damages and interest.
The Financial Service Board has penalised Discovery for promoting “rewards” which are unrelated to actual benefits.
Mediclinic International has reported a 16% increase in normalised revenue to R19 565m in its results for the six months to end-September.
A skills transfer agreement between US pharmaceutical giant Pfizer and Biovac to manufacture a pneumonia vaccine will create at least 183 jobs in the Western Cape.
British drugmaker AstraZeneca has agreed to buy US group ZS Pharma, a specialist in treating high potassium levels linked to kidney disease and heart failure.
French pharmaceuticals giant Sanofi says that profits would stagnate for the next two years, prompting a heavy sell-off of its shares on the Paris stock exchange.
SA's planned nuclear would be a financial, environmental, and ethical disaster, says user.
Columnist Andrew Donaldson tackles the ANC's rotting corpse in his book.
A new definition of expropriation has a potential risk for all who own any form of property in SA.
Most Fin24 users are sceptical about the idea of banks rolling out fingerprint ATMs.
A closer look at three firms that offer value despite the market trading at all-time highs.
An economist questions Sarb's theory of using inflation targeting as the measure for rate hikes.
Your credit rating can determine the cost of your debt.
Data shows SA has narrowly shunned recession, but many say it's still inevitable.
Pfizer chief executive is trying for the second time in as many years to do a deal with a foreign firm that could produce the savings he has been unable to extract from Washington.
As big drug makers race to launch the effective treatments for leukemia and other blood cancers, they are grappling with how to make them available and cost-efficiently.
Financial services company Discovery says it is giving away Apple Watch wearable devices - but at an exercising cost.
Going to negatively affect consumers this festive season
Not that bad - it’s a small increase
I don’t care, it doesn’t affect me
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Lost? Confused? Problems? Let us help you.